Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

535
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
535
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

1.5K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

211
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
211
Factors Affecting Solubility04:01

Factors Affecting Solubility

33.5K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
33.5K
Factors Influencing Drug Absorption: Physicochemical Parameters01:22

Factors Influencing Drug Absorption: Physicochemical Parameters

305
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
305
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

866
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
866

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.

Therapeutic advances in medical oncology·2026
Same author

An In Vitro Study of Protein S-Glutathionylation by Members of the CLIC Protein Family.

Biomolecules·2025
Same author

Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant Subtypes.

Cancers·2024
Same author

<i>In Vitro</i> Enzymatic Studies Reveal pH and Temperature Sensitive Properties of the CLIC Proteins.

Biomolecules·2023
Same author

Sterol Structural Features' Impact on the Spontaneous Membrane Insertion of CLIC1 into Artificial Lipid Membranes.

Langmuir : the ACS journal of surfaces and colloids·2023
Same author

Cholic Acid-Based Antimicrobial Peptide Mimics as Antibacterial Agents.

International journal of molecular sciences·2022

相关实验视频

Updated: Jul 13, 2025

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.2K

改善大麻醇可溶性的当前挑战和机会

Khondker Rufaka Hossain1, Amani Alghalayini1,2, Stella M Valenzuela1,2

  • 1School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, Australia.

International journal of molecular sciences
|October 14, 2023
PubMed
概括

大麻二醇 (CBD) 的生物可用性较低,限制了其治疗用途. 像纳米乳液和纳米载体这样的新兴策略旨在提高CBD的吸收和有效性,用于各种医疗条件.

关键词:
在这里,我们可以看到CBD CBD CBD CBD.生物可用性 生物可用性在Cannabidiol中使用.溶解度 溶解度 溶解度 溶解度稳定的稳定性 稳定的稳定性

更多相关视频

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.8K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.1K

相关实验视频

Last Updated: Jul 13, 2025

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.2K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.8K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.1K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 药物输送系统 药物输送系统
  • 大麻科学 大麻科学

背景情况:

  • 大麻衍生化合物大麻二醇 (CBD) 显示出治疗前景,但其口服生物可用性较差.
  • 低生物可用性限制了CBD达到全身循环的量,阻碍了其临床疗效.
  • 提高CBD生物可用性对于最大限度地发挥其在各种医疗应用中的治疗潜力至关重要.

研究的目的:

  • 审查当前对大麻素 (CBD) 生物可用性挑战的理解.
  • 探索改善CBD吸收和生物可用性的新兴策略.
  • 讨论新的配方方法,以改善治疗结果.

主要方法:

  • 对CBD生物可用性现有研究的文献综述.
  • 分析各种配方策略,包括纳米乳液,基于脂质的系统和纳米载体.
  • 讨论改善CBD输送的替代管理途径.

主要成果:

  • 几种先进的配方技术显示了显著增加CBD生物可用性的潜力.
  • 基于纳米乳液的系统,脂质配方和纳米载体有望提高CBD吸收.
  • 其他注射途径可能会绕过第一通代谢,从而改善全身可用性.

结论:

  • 提高CBD生物可用性是释放其全部治疗益处的关键.
  • 新型药物输送系统为克服当前局限性提供了有希望的解决方案.
  • 对优化配方的进一步研究将导致更有效的基于CBD的疗法.